Information Journal Paper
APA:
Copy. (2017). Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer. BREAST CANCER, 24(1), 147-151. SID. https://sid.ir/paper/726704/en
Vancouver:
Copy. Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer. BREAST CANCER[Internet]. 2017;24(1):147-151. Available from: https://sid.ir/paper/726704/en
IEEE:
Copy, “Efficacy and safety of re-induction therapy with bevacizumab and paclitaxel for metastatic breast cancer,” BREAST CANCER, vol. 24, no. 1, pp. 147–151, 2017, [Online]. Available: https://sid.ir/paper/726704/en